10 likes | 158 Views
In vivo Analysis. A : Tumor progression in C57BL/6 Mice. 600. 500. 400. B16.F10. B16.F10 TFG HTLV-1 ZEO. 300. B16.F10 TFG FGF-2 ZEO. Mean tumor size (mm2). B16.F10 TFG EMCV ZEO. 200. B16.F10 DFG70 and DFG80. 100. 0. 0. 4. 8. 12. 15. 19. Days. B : Tumor progression in BALB/c.
E N D
In vivo Analysis A : Tumor progression in C57BL/6 Mice 600 500 400 B16.F10 B16.F10 TFG HTLV-1ZEO 300 B16.F10 TFGFGF-2ZEO Mean tumor size (mm2) B16.F10 TFGEMCVZEO 200 B16.F10 DFG70 and DFG80 100 0 0 4 8 12 15 19 Days B : Tumor progression in BALB/c 140 TS/A WT 120 100 TS/A TFGEMCVZEO 80 CD70) (23%CD70 and CD80, 34% Mean tumor size (mm2) 60 TS/A TFGFGF-2ZEO 40 (17%CD70 and CD80, 73 % CD70) 20 TS/A DFG70 and DFG80 0 (68% CD70 and CD80) -20 0 7 11 17 21 Days